tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Mccarthy, 201 are a BUY (83.4%), 37 are a HOLD (15.35%), 3 are a SELL (1.24%).
Analyst Jason Mccarthy, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 38.65% that have a potential upside of 58.54% achieved within 228 days.
Jason Mccarthy’s has documented 466 price targets and ratings displayed on 72 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BNGO, Bionano Genomics at 19-May-2025.
Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 9/17/2024. The price target of $12 was fulfilled within 13 days with a profit of $6.92 (136.22%) receiving and performance score of 104.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$20
$14.26 (248.43%)
$15
2 months 14 days ago
(29-Apr-2025)
0/7 (0%)
$13.44 (204.88%)
Buy
$18
$12.26 (213.59%)
$18
8 months 15 days ago
(28-Oct-2024)
1/5 (20%)
$11.43 (173.97%)
61
Hold
$6
$0.26 (4.53%)
$25
2 years 8 months ago
(13-Nov-2022)
1/2 (50%)
$1.85 (44.58%)
452
Buy
$75
$70.79 (1681.47%)
$50
4 years 8 months 3 days ago
(11-Nov-2020)
2/3 (66.67%)
$45.92 (117.11%)
101
Buy
$22
5 years 2 months 6 days ago
(07-May-2020)
1/3 (33.33%)
$-59.25 (-72.92%)
820
Which stock is Jason Mccarthy is most bullish on?
Which stock is Jason Mccarthy is most reserved on?
What Year was the first public recommendation made by Jason Mccarthy?
